🇺🇸 FDA
Patent

US 11419875

Compounds and compositions for treating hematological disorders

granted A61KA61K31/416A61K31/422

Quick answer

US patent 11419875 (Compounds and compositions for treating hematological disorders) held by Aurigene Discovery Technologies Limited expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aurigene Discovery Technologies Limited
Grant date
Tue Aug 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
51
CPC classes
A61K, A61K31/416, A61K31/422, A61K31/437, A61K31/4439